Condition: Major Depression Disorder · Sponsor: Ionclinics & Deionic SL
The purpose of this multicentric randomized controlled trial is to compare the effectiveness and safety of home-based tDCS for the treatment of major depression versus tDCS treatment in a healthcare centre, and explore the effects of an accelerated home-tDCS protocol. The change in depression index at the end of treatment, measured with MADRS, will be the primary outcome.
This description comes directly from the study's public registry record.
Ane Miren Gutiérrez Muto, PhD · +34960606200 · investigacion@ionclinics.com
Ensayos Ionclincs · +34674059324 · ensayos@ionclinics.com
Always discuss trial participation with your own doctor first.
| Hospital Universitario de Bellvitge | L'Hospitalet de Llobregat, Barcelona, Spain | Recruiting |
| Hospital Universitari de Mataró | Mataró, Barcelona, Spain | Recruiting |
| Parc Taulí Hospital Universitari | Sabadell, Barcelona, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07510880